Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1351 clinical trials
  • 0 views
  • 11 Apr, 2025
Program-P1  

Test Program-01

  • 0 views
  • 17 Nov, 2025
RJ_Study_Virtual1  

Acne

Virtual trials
  • 0 views
  • 14 Mar, 2022
  • Online study
Virtual Trial 04  

test comment here.

Accepts healthy volunteers
Online studies
  • 0 views
  • 14 Mar, 2022
  • 1 location
  • Online study
Second Primary Lung Cancer Cohort Study (SPORT) (SPORT)  

Patients who have had curative treatment for lung cancer are at an increased risk of developing second primary lung cancers (and other cancers) over the next 10 years. Doctors need to develop better ways of monitoring patients during follow up so we can intervene as quickly as possible with further …

Online studies
  • 0 views
  • 12 Feb, 2026
  • 1 location
  • Online study
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)  

The Swiss-Ped-IBrainD is a national patient registry that collects information on diagnosis, symptoms, treatment, and follow-up of pediatric patients with an inflammatory brain disease in Switzerland. It was first implemented in 2020 in the pediatric clinic of the university hospital in Bern. Further centers all over Switzerland were opened for …

neuromyelitis optica
multiple sclerosis
optic neuritis
Online studies
myelitis
  • 0 views
  • 14 Mar, 2022
  • 1 location
  • Online study
A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis

The present trial will be performed to characterize the dose-response curve for BI 655130 in patients with a history of Generalized Pustular Psoriasis (GPP, per European Rare and Severe Psoriasis Expert Network (ERASPEN) criteria) who are now (at screening and at randomization) presenting with a Generalized Pustular Psoriasis Physician Global …

  • 0 views
  • 16 Feb, 2024
  • 20 locations
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease  

This is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab versus placebo in participants with Early Parkinson's Disease (PD) who are on stable symptomatic PD medication.

resting tremor
bradykinesia
tremor
dopamine transporter
early parkinson's
  • 0 views
  • 28 Jun, 2022
  • 126 locations
Test_additional_reports  

test

Accepts healthy volunteers
  • 0 views
  • 06 Nov, 2023
  • 5 locations
  • 0 views
  • 23 Mar, 2022
  • 14 locations